Neutrophil lymphocyte ratios in stroke subtypes and transient ischemic attack

Basit Öğe Kaydı
dc.contributor.authorGokhan, S.
dc.contributor.authorOzhasenekler, A.
dc.contributor.authorDurgun, H. Mansur
dc.contributor.authorAkil, E.
dc.contributor.authorUstundag, M.
dc.contributor.authorOrak, M.
dc.date.accessioned2024-04-24T17:37:41Z
dc.date.available2024-04-24T17:37:41Z
dc.date.issued2013
dc.departmentDicle Üniversitesien_US
dc.description.abstractOBJECTIVES: This investigation was conducted to test the value of Neutrophil Lymphocyte Ratio (NLR), which has been shown in some recent studies to be a prognostically important and an easy-to-measure inflammatory marker, in patients presenting to Emergency Service with stroke (ischemic and hemorrhagic) and transient ischemic attack. MATERIALS AND METHODS: A total of 868 patients were enrolled, who presented to our Emergency Service with cerebrovascular accident (stroke and transient ischemic attack) and admitted to Neurology Clinic. Demographic characteristics and comorbidities of patients were recorded. The patients were divided into 3 groups as acute ischemic stroke (AIS), acute hemorrhagic stroke (AHS) and transient ischemic attack (TIA). Patients with AIS were classified into subgroups in terms of TOAST (trial of 10172 stroke treatment) criteria. Admission NLR levels were compared across all groups. RESULTS: A total of 868 patients were enrolled, 51.6% of which were male and 48.4% were female. AIS rate was 75.3%, AHS rate was 14.3% and TIA rate was 10.7%. In all of patients, mortality rate was 10.7%. NLR was significantly higher in patients who died (p < 0.001). NLR level in patients with TIA was significantly lower than those of AIS and AHS groups (p < 0.001). Among AIS subgroups, NLR level was significantly higher in group with great artery atherosclerosis or atherothrombosis compared to other groups (p < 0.001). CONCLUSIONS: NLR may be used as a simple and easy-to-measure marker for prediction of short-term prognosis and in-hospital mortality in both ischemic and hemorrhagic stroke patients.en_US
dc.identifier.endpage657en_US
dc.identifier.issn1128-3602
dc.identifier.issue5en_US
dc.identifier.pmid23543449en_US
dc.identifier.scopus2-s2.0-84878582775en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage653en_US
dc.identifier.urihttps://hdl.handle.net/11468/21117
dc.identifier.volume17en_US
dc.identifier.wosWOS:000319225900010en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherVerduci Publisheren_US
dc.relation.ispartofEuropean Review For Medical and Pharmacological Sciencesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectNeutrophil Lymphocyte Ratioen_US
dc.subjectStrokeen_US
dc.subjectTransient Ischemic Attacken_US
dc.titleNeutrophil lymphocyte ratios in stroke subtypes and transient ischemic attacken_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu